{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:32:28Z","timestamp":1787236348157,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,21]],"date-time":"2012-10-21T00:00:00Z","timestamp":1350777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10620-012-2378-y","type":"journal-article","created":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T04:39:15Z","timestamp":1350707955000},"page":"344-348","source":"Crossref","is-referenced-by-count":9,"title":["Overlap Syndromes of Autoimmune Hepatitis: An Open Question"],"prefix":"10.1007","volume":"58","author":[{"given":"Marilena","family":"Durazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Premoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Paschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Belci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Spandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,21]]},"reference":[{"key":"2378_CR1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1023\/A:1022597210629","volume":"48","author":"M Durazzo","year":"2003","unstructured":"Durazzo M, Premoli A, Fagoonee S, Pellicano R. Overlap syndrome of autoimmune hepatitis: what is known so far. Dig Dis Sci. 2003;48:423\u2013430.","journal-title":"Dig Dis Sci"},{"key":"2378_CR2","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1023\/A:1010620122567","volume":"46","author":"KW Burak","year":"2001","unstructured":"Burak KW, Urbanski SJ, Swain MG. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases. Dig Dis Sci. 2001;46:2043\u20132047.","journal-title":"Dig Dis Sci"},{"key":"2378_CR3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/00042737-200510000-00011","volume":"17","author":"JG Kingham","year":"2005","unstructured":"Kingham JG, Abbasi A. Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective. Eur J Gastroenterol Hepatol. 2005;17:1077\u20131080.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2378_CR4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.1840190407","volume":"19","author":"JM Pawlotsky","year":"1994","unstructured":"Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology. 1994;19:841\u2013848.","journal-title":"Hepatology"},{"key":"2378_CR5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1365-2249.2003.02030.x","volume":"131","author":"P Muratori","year":"2003","unstructured":"Muratori P, Muratori L, Stroffolini T, et al. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol. 2003;131:118\u2013121.","journal-title":"Clin Exp Immunol"},{"key":"2378_CR6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0168-8278(99)80404-8","volume":"31","author":"F Lunel","year":"1999","unstructured":"Lunel F, Cacoub P. Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection. J Hepatol. 1999;31:210\u2013216.","journal-title":"J Hepatol"},{"key":"2378_CR7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2005-916322","volume":"25","author":"U Beuers","year":"2005","unstructured":"Beuers U, Rust C. Overlap syndromes. Semin Liver Dis. 2005;25:311\u2013320.","journal-title":"Semin Liver Dis"},{"key":"2378_CR8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","volume":"44","author":"R Poupon","year":"2006","unstructured":"Poupon R, Chazouilleres O, Corpechot C, Chr\u00e9tien Y. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis. Hepatology. 2006;44:85\u201390.","journal-title":"Hepatology"},{"key":"2378_CR9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","volume":"28","author":"O Chazouilleres","year":"1998","unstructured":"Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998;28:296\u2013301.","journal-title":"Hepatology"},{"key":"2378_CR10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","volume":"54","author":"KM Boberg","year":"2011","unstructured":"Boberg KM, Chapman RW, Hirschfield GM, et al. Overlap syndromes: the international autoimmune hepatitis group (IAIHG) position statement on a controversial issue. J Hepatol. 2011;54:374\u2013385.","journal-title":"J Hepatol"},{"key":"2378_CR11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","volume":"28","author":"AJ Czaja","year":"1998","unstructured":"Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology. 1998;28:360\u2013365.","journal-title":"Hepatology"},{"key":"2378_CR12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","volume":"125","author":"AJ Czaja","year":"1996","unstructured":"Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med. 1996;125:588\u2013598.","journal-title":"Ann Intern Med"},{"key":"2378_CR13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cgh.2011.03.019","volume":"9","author":"A Bonder","year":"2011","unstructured":"Bonder A, Retana A, Winston DM, Leung J, Kaplan MM. Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol. 2011;9:609\u2013612.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2378_CR14","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","volume":"29","author":"AW Lohse","year":"1999","unstructured":"Lohse AW, zum Buschenfelde KH, Franz B, Kanzler S, Gerken G, et al. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology. 1999;29:1078\u20131084.","journal-title":"Hepatology"},{"key":"2378_CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0399-8320(07)89323-7","volume":"31","author":"A Heurgu\u00e8","year":"2007","unstructured":"Heurgu\u00e8 A, Vitry F, Diebold MD, et al. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroenterol Clin Biol. 2007;31:17\u201325.","journal-title":"Gastroenterol Clin Biol"},{"key":"2378_CR16","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FP, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:928\u2013937.","journal-title":"J Hepatol"},{"key":"2378_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u2013176.","journal-title":"Hepatology"},{"key":"2378_CR18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","volume":"8","author":"EMM Kuiper","year":"2010","unstructured":"Kuiper EMM, Zondervan PE, Van Buuren HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol. 2010;8:530\u2013534.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2378_CR19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"EASL Clinical Practice Guidelines","year":"2009","unstructured":"EASL Clinical Practice Guidelines. Management of cholestatic liver diseases. J Hepatol. 2009;51:237\u2013267.","journal-title":"J Hepatol"},{"key":"2378_CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","volume":"28","author":"T Al-Chalabi","year":"2008","unstructured":"Al-Chalabi T, Portmann BC, Bernal W, Mcfarlane IG, Heneghan MA. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival. Aliment Pharmacol Ther. 2008;28:209\u2013220.","journal-title":"Aliment Pharmacol Ther"},{"key":"2378_CR21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cgh.2010.04.007","volume":"8","author":"C Efe","year":"2010","unstructured":"Efe C, Purnak T, Ozaslan E. The diagnostic criteria for patients with autoimmune hepatitis and primary biliary cirrhosis overlap syndrome. Clin Gastroenterol Hepatol. 2010;8:734.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2378_CR22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s12072-009-9155-9","volume":"3","author":"Y Miyake","year":"2009","unstructured":"Miyake Y, Iwasaki Y, Kobashi H, et al. Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis. Hepatol Int. 2009;3:556\u2013562.","journal-title":"Hepatol Int"},{"key":"2378_CR23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","volume":"35","author":"S Joshi","year":"2002","unstructured":"Joshi S, Cauch-Dudek K, Wanless IR, et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology. 2002;35:409\u2013413.","journal-title":"Hepatology"},{"key":"2378_CR24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","volume":"44","author":"O Chazouill\u00e8res","year":"2006","unstructured":"Chazouill\u00e8res O, Wendum D, Serfaty L, Rosmorduc O, Poupon R. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol. 2006;44:400\u2013406.","journal-title":"J Hepatol"},{"key":"2378_CR25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2005.11.037","volume":"44","author":"AJ Czaja","year":"2006","unstructured":"Czaja AJ. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries. J Hepatol. 2006;44:251\u2013252.","journal-title":"J Hepatol"},{"key":"2378_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3748\/wjg.14.331","volume":"14","author":"R Saich","year":"2008","unstructured":"Saich R, Chapman R. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol. 2008;14:331\u2013337.","journal-title":"World J Gastroenterol"},{"key":"2378_CR27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","volume":"20","author":"R Olsson","year":"2009","unstructured":"Olsson R, Glaumann H, Almer S, et al. High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis. Eur J Intern Med. 2009;20:190\u2013196.","journal-title":"Eur J Intern Med"},{"key":"2378_CR28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00042737-200406000-00012","volume":"16","author":"L Gheorghe","year":"2004","unstructured":"Gheorghe L, Iacob S, Gheorghe C, et al. Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease. Eur J Gastroenterol Hepatol. 2004;16:585\u2013592.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2378_CR29","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2011.04658.x","volume":"33","author":"EL Culver","year":"2011","unstructured":"Culver EL, Chapman RW. Systematic review: management options for primary sclerosing cholangitis and its variant forms\u2014IgG4-associated cholangitis and overlap with autoimmune hepatitis. Aliment Pharmacol Ther. 2011;33:1273\u20131291.","journal-title":"Aliment Pharmacol Ther"},{"key":"2378_CR30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3748\/wjg.v16.i8.934","volume":"16","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ. Difficult treatment decisions in autoimmune hepatitis. World J gastroenterol. 2010;16:934\u2013947.","journal-title":"World J gastroenterol"},{"key":"2378_CR31","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3748\/wjg.14.3368","volume":"14","author":"C Rust","year":"2008","unstructured":"Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol. 2008;14:3368\u20133373.","journal-title":"World J Gastroenterol"},{"key":"2378_CR32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","volume":"43","author":"S L\u00fcth","year":"2009","unstructured":"L\u00fcth S, Kanzler S, Frenzel C, et al. Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. J Clin Gastroenterol. 2009;43:75\u201380.","journal-title":"J Clin Gastroenterol"},{"key":"2378_CR33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PG Johnson","year":"1993","unstructured":"Johnson PG, McFarlane IG. Meeting report: international autoimmune hepatitis group. Hepatology. 1993;18:998\u20131005.","journal-title":"Hepatology"},{"key":"2378_CR34","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","volume":"121","author":"SA Mitchell","year":"2001","unstructured":"Mitchell SA, Bansi DS, Hunt N, et al. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology. 2001;121:900\u2013907.","journal-title":"Gastroenterology"},{"key":"2378_CR35","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2036.2011.04822.x","volume":"34","author":"CK Triantos","year":"2011","unstructured":"Triantos CK, Koukias NM, Nikolopoulou VN, Burroughs AK. Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther. 2011;34:901\u2013910.","journal-title":"Aliment Pharmacol Ther"},{"key":"2378_CR36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2036.2011.04966.x","volume":"35","author":"L Lindstr\u00f6m","year":"2012","unstructured":"Lindstr\u00f6m L, Boberg KM, Wikman O, et al. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. Aliment Pharmacol Ther. 2012;35:451\u2013457.","journal-title":"Aliment Pharmacol Ther"},{"key":"2378_CR37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MPG.0b013e3181a1c265","volume":"49","author":"G Mieli-Vergani","year":"2009","unstructured":"Mieli-Vergani G, Heller S, Jara P, et al. Autoimmune hepatitis. J Pediatr Gastroenterol Nutr. 2009;49:158\u2013164.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2378_CR38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/jhep.2003.50289","volume":"38","author":"AE Feldstein","year":"2003","unstructured":"Feldstein AE, Perrault J, El-Youssif M, Lindor KD, Freese DK, Angulo P. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology. 2003;38:210\u2013217.","journal-title":"Hepatology"},{"key":"2378_CR39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000273735","volume":"82","author":"TA Malik","year":"2010","unstructured":"Malik TA, Gutierrez AM, McGuire B, et al. Autoimmune hepatitis-primary sclerosing cholangitis overlap syndrome complicated by Crohn\u2019s disease. Digestion. 2010;82:24\u201326.","journal-title":"Digestion"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-012-2378-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-012-2378-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-012-2378-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:45:06Z","timestamp":1559231106000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-012-2378-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,21]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["2378"],"URL":"https:\/\/doi.org\/10.1007\/s10620-012-2378-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,21]]}}}